|
Global Gastric Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Clostridium difficile Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Non-Hodgkin Lymphoma Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Obesity Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Injectable Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
230 |
Global |
$1,995.00 |
|
|
Global Esophageal Reflux Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Osteoporosis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Migraine Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Infectious Diseases Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
800 |
Global |
$3,495.00 |
|
|
Global Transplantation Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Cervical Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Dengue Fever Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Acute and Chronic Myelogenous Leukemia Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Attention Deficit Disorder Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Topical Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
180 |
Global |
$1,995.00 |
|
|
Global Gastrointestinal Symptoms Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Osteoarthritis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Multiple Sclerosis Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Hospital Care Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
900 |
Global |
$3,495.00 |
|
|
Global Accident & Emergency Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Brain Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players |
May 4 2018 |
140 |
Global |
$2,995.00 |
|
|
Acne Vulgaris - Epidemiology Forecast to 2026 |
Mar 1 2018 |
37 |
Global |
$3,995.00 |
|
|
OpportunityAnalyzer: Late - Stage Chronic Kidney Disease - Opportunity Analysis and Forecasts to 2026 |
Dec 31 2017 |
195 |
Global |
$10,995.00 |
|
|
PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
185 |
Global |
$10,995.00 |
|
|
PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
280 |
Global |
$10,995.00 |
|
|
Global Allergy Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Zeltia Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Autoimmune Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
700 |
Global |
$2,995.00 |
|
|
Galderma Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
